Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: MCR011
MIFTS: 43

Microinvasive Gastric Cancer

Categories: Cancer diseases, Gastrointestinal diseases
Genes Tissues Related diseases Publications Pathways Symptoms & Phenotypes Drugs
Sources

Aliases & Classifications for Microinvasive Gastric Cancer

About this section

MalaCards integrated aliases for Microinvasive Gastric Cancer:

Name: Microinvasive Gastric Cancer 12 15
Early Gastric Cancer 12 55 15 72
Surface Gastric Cancer 12

Classifications:

MalaCards categories:
Global: Cancer diseases
Anatomical: Gastrointestinal diseases
See all MalaCards categories (disease lists)


External Ids:

Disease Ontology 12 DOID:10541
NCIt 50 C27131
UMLS 72 C0349530
Sources

Summaries for Microinvasive Gastric Cancer

About this section
MalaCards based summary : Microinvasive Gastric Cancer, also known as early gastric cancer, is related to peptic esophagitis and bile reflux, and has symptoms including abdominal pain and dyspepsia. An important gene associated with Microinvasive Gastric Cancer is TDRG1 (Testis Development Related 1), and among its related pathways/superpathways are Gastric cancer and Colorectal Cancer Metastasis. The drugs Clarithromycin and Amoxicillin have been mentioned in the context of this disorder. Affiliated tissues include lymph node, liver and colon, and related phenotype is digestive/alimentary.

Sources

Related Diseases for Microinvasive Gastric Cancer

About this section

Diseases related to Microinvasive Gastric Cancer via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 343)
# Related Disease Score Top Affiliating Genes
1 peptic esophagitis 31.3 ATP4A ATP12A
2 bile reflux 30.4 CDX2 ATP4A ATP12A
3 hernia, hiatus 30.3 ATP4A ATP12A
4 esophageal varix 30.3 ATP4A ATP12A
5 papillary adenocarcinoma 30.3 TP53 CEACAM5 CDH1
6 gastric neuroendocrine neoplasm 30.1 ATP4A ATP12A
7 rectum adenocarcinoma 30.1 CEACAM5 CDX2
8 aspiration pneumonia 30.0 ATP4A ATP12A
9 intrahepatic cholangiocarcinoma 29.9 TP53 CDX2 CDH1
10 familial adenomatous polyposis 29.8 TP53 MLH1 CDH1
11 gastric lymphoma 29.7 TP53 ATP4A ATP12A
12 gastric cancer 29.7 XIST VEGFC TP53 TDRG1 MLH1 CEACAM5
13 gastric adenocarcinoma 29.2 VEGFC TP53 MLH1 CEACAM5 CDX2 CDH1
14 gastrointestinal system cancer 29.1 TP53 MLH1 CEACAM5 CDX2 CDH1
15 cholangiocarcinoma 28.7 VEGFC TP53 CEACAM5 CDX2 CDH1
16 pancreatic cancer 28.5 XIST TP53 CEACAM5 CDX2 CDH1
17 esophageal cancer 28.4 XIST VEGFC TP53 CEACAM5 CDX2 CDH1
18 colorectal cancer 27.9 XIST VEGFC TP53 MLH1 CEACAM5 CDX2
19 gastritis 10.7
20 adenocarcinoma 10.6
21 signet ring cell adenocarcinoma 10.6
22 gastric diffuse adenocarcinoma 10.6 CDX2 CDH1
23 adenosquamous colon carcinoma 10.6 MLH1 CDX2
24 adenoma 10.5
25 tubular adenocarcinoma 10.5
26 esophagitis 10.5
27 helicobacter pylori infection 10.5
28 atrophic gastritis 10.5
29 dumping syndrome 10.5
30 gastric ulcer 10.4
31 esophageal adenosquamous carcinoma 10.4 CEACAM5 CDH1
32 anal paget's disease 10.4 CEACAM5 CDX2
33 fungal esophagitis 10.4 ATP4A ATP12A
34 anus adenocarcinoma 10.4 CEACAM5 CDX2
35 mucinous adenofibroma 10.4 CEACAM5 CDX2
36 gastroduodenal crohn's disease 10.4 ATP4A ATP12A
37 diclofenac allergy 10.4 ATP4A ATP12A
38 neonatal candidiasis 10.4 ATP4A ATP12A
39 squamous papillomatosis 10.4 ATP4A ATP12A
40 photoallergic dermatitis 10.4 ATP4A ATP12A
41 gastrointestinal neuroendocrine benign tumor 10.4 ATP4A ATP12A
42 aspiration pneumonitis 10.4 ATP4A ATP12A
43 toxic megacolon 10.4 ATP4A ATP12A
44 granulomatous gastritis 10.4 ATP4A ATP12A
45 gastric antral vascular ectasia 10.4 ATP4A ATP12A
46 acute laryngitis 10.4 ATP4A ATP12A
47 laryngitis 10.4 ATP4A ATP12A
48 thymus adenocarcinoma 10.4 CEACAM5 CDX2
49 esophageal candidiasis 10.4 ATP4A ATP12A
50 duodenitis 10.4 ATP4A ATP12A

Graphical network of the top 20 diseases related to Microinvasive Gastric Cancer:



Diseases related to Microinvasive Gastric Cancer
Sources

Symptoms & Phenotypes for Microinvasive Gastric Cancer

About this section

UMLS symptoms related to Microinvasive Gastric Cancer:


abdominal pain, dyspepsia

MGI Mouse Phenotypes related to Microinvasive Gastric Cancer:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 digestive/alimentary MP:0005381 9.1 ATP12A ATP4A CDH1 CDX2 MLH1 TP53
Sources

Drugs & Therapeutics for Microinvasive Gastric Cancer

About this section

Drugs for Microinvasive Gastric Cancer (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 132)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Clarithromycin Approved Phase 4 81103-11-9 84029
2
Amoxicillin Approved, Vet_approved Phase 4 26787-78-0 33613
3
Pantoprazole Approved Phase 4 102625-70-7 4679
4
Clopidogrel Approved Phase 4 113665-84-2, 120202-66-6 60606
5
Aspirin Approved, Vet_approved Phase 4 50-78-2 2244
6
Dexlansoprazole Approved, Investigational Phase 4 103577-45-3, 138530-94-6 9578005
7
Metronidazole Approved Phase 4 443-48-1 4173
8
Lansoprazole Approved, Investigational Phase 4 103577-45-3 3883
9
Rabeprazole Approved, Investigational Phase 4 117976-89-3 5029
10
Magnesium Sulfate Approved, Investigational, Vet_approved Phase 4 7487-88-9 24083
11
Calcium Approved, Nutraceutical Phase 4 7440-70-2 271
12
Ecabet Investigational Phase 4 33159-27-2, 86408-72-2 65781
13 Analgesics, Non-Narcotic Phase 4
14 Cyclooxygenase Inhibitors Phase 4
15 Fibrinolytic Agents Phase 4
16 Purinergic P2Y Receptor Antagonists Phase 4
17 Anti-Inflammatory Agents, Non-Steroidal Phase 4
18 Purinergic P2 Receptor Antagonists Phase 4
19 Platelet Aggregation Inhibitors Phase 4
20 Anti-Inflammatory Agents Phase 4
21 Antirheumatic Agents Phase 4
22 Antipyretics Phase 4
23 Cytochrome P-450 CYP3A Inhibitors Phase 4
24 Anti-Infective Agents Phase 4
25 Cytochrome P-450 Enzyme Inhibitors Phase 4
26 Anti-Bacterial Agents Phase 4
27 Antiparasitic Agents Phase 4
28 Antiprotozoal Agents Phase 4
29 HIV Protease Inhibitors Phase 4
30
protease inhibitors Phase 4
31 Protective Agents Phase 4
32 Gastrointestinal Agents Phase 4
33 Antacids Phase 4
34 Proton Pump Inhibitors Phase 4
35 Anti-Ulcer Agents Phase 4
36 Analgesics Phase 4
37 Peripheral Nervous System Agents Phase 4
38 Central Nervous System Depressants Phase 4
39 Anesthetics Phase 4
40 Hormones Phase 4
41 Tocolytic Agents Phase 4
42 Anti-Arrhythmia Agents Phase 4
43 Anticonvulsants Phase 4
44 calcium channel blockers Phase 4
45 Calcium, Dietary Phase 4
46
Meperidine Approved Phase 3 57-42-1 4058
47
Omeprazole Approved, Investigational, Vet_approved Phase 3 73590-58-6 4594
48
Menthol Approved Phase 3 2216-51-5 16666
49
Racepinephrine Approved Phase 3 329-65-7 838
50
Epinephrine Approved, Vet_approved Phase 3 51-43-4 5816

Interventional clinical trials:

(show top 50) (show all 106)
# Name Status NCT ID Phase Drugs
1 Effects of Ilaprazole 20mg on Ulcer Healing Rate and Prevention of Gastrointestinal Bleeding in the Patients Undergone Endoscopic Submucosal Dissection(ESD) for Gastric Adenoma or Early Gastric Cancer. Unknown status NCT02638584 Phase 4 Ilaprazole;Rabeprazole
2 Does Early Re-administration of Aspirin/Clopidogrel Increase the Risk of Bleeding From Artificial Ulcer After EMR or ESD? Unknown status NCT01621451 Phase 4 aspirin and/or clopidogrel;aspirin and/or clopidogrel
3 Efficacy of an Ecabet Sodium and Proton Pump Inhibitor (PPI) Combination Therapy in the Treatment of Iatrogenic Ulcer After Endoscopic Submucosal Dissection: A Prospective Randomized Controlled Trial Unknown status NCT01308177 Phase 4 Ecabet
4 Helicobacter Pylori Eradication Rates of Concomitant Therapy and Tailored Therapy Based on 23S Ribosomal RNA Point Mutations Associated With Clarithromycin Resistance: A Multicenter Prospective Randomized Study Unknown status NCT03130452 Phase 4 Lansoprazole 30mg;Amoxicillin 1.0g Tab;Clarithromycin 500mg;Metronidazole 500 mg
5 The Effect of Perioperative Intravenous Magnesium on Pain After Endoscopic Submucosal Dissection for Gastric Neoplasm: Prospective Randomized Double-blind Placebo Controlled Study Completed NCT02235246 Phase 4 Magnesium Sulfate;Normal saline
6 Effects of Preoperative Administration of Oral Rabeprazole on the Prevention of Ulcer Bleeding Following Endoscopic Mucosal Resection(EMR): Prospective, Randomized, Placebo-controlled, Comparative Study Completed NCT00844675 Phase 4 rabeprazole;placebo
7 Efficacy of Bispectral Index Monitoring for Midazolam and Meperidine Induced Sedation During Endoscopic Submucosal Dissection Unknown status NCT01157598 Phase 3
8 Morbidity and Mortality of Laparoscopy-assisted and Open Distal Gastrectomy for Gastric Cancer in the Elderly Patients: A Randomized Controlled Trial Unknown status NCT02246153 Phase 3
9 Multicenter Study on Comparison of Long-term Outcome Between Laparoscopic and Open Distal Subtotal Gastrectomy With D2 Lymphadenectomy for Locally Advanced Gastric Cancer Unknown status NCT01609309 Phase 3
10 Effect of Helicobacter Pylori Eradication on the New Tumor Development After Endoscopic Resection of Gastric Tumors Completed NCT01510730 Phase 3 eradication treatment of Helicobacter pylori infection
11 Phase III Placebo-controlled Study of NPO-11 in Patients Undergoing Therapeutic Upper Gastrointestinal Endoscopy (Randomized, Double-blind, Parallel-assignment, Placebo-controlled Study) Completed NCT01411176 Phase 3 Menthol;Placebo
12 Prospective Randomized Trial of Laparoscopy-assisted Distal Gastrectomy (LADG) Versus Open Distal Gastrectomy (ODG) in Patients With Early Gastric Cancer (EGC) Completed NCT00546468 Phase 3
13 Multicenter Randomized Controlled Trial Comparing Laparoscopic Pylorus Preserving Gastrectomy Versus Laparoscopic Distal Gastrectomy for the Middle Third Early Gastric Cancer (KLASS-04) Recruiting NCT02595086 Phase 3
14 Prospective Multicenter Study on Laparoscopic Gastric Cancer Surgery Compared With Open Surgery for Locally Advanced Gastric Cancer Recruiting NCT02748551 Phase 3
15 Multicenter Phase III Trial of Laparoscopic Sentinel Node Biopsy and Stomach Preserving Surgery in Early Gastric Cancer Active, not recruiting NCT01804998 Phase 3
16 Multicenter Randomized Controlled Trial of Gastric Endoscopic Submucosal Dissection With or Without Epineprhine Added Solution Not yet recruiting NCT04032119 Phase 3 Epinephrine
17 Phase III Study on Comparison for Bile Reflux and Gastric Stasis in Patients With Gastric Cancer After Distal Gastrectomy Withdrawn NCT00622804 Phase 3
18 A Phase II Study of Robot Assisted Distal Gastrectomy With Nodal Dissection for Clinical Stage Ia Gastric Cancer Unknown status NCT01504997 Phase 2
19 The Effect of Uncut Roux-en-Y Gastrojejunostomy on Quality of Life After Laparoscopic Distal Gastrectomy for Early Gastric Cancer Patients Unknown status NCT02644148 Phase 2
20 Prospective Multi-center Study of Laparoscopy-assisted Total Gastrectomy for Clinical Stage I Gastric Cancer (KLASS-03) Unknown status NCT01584336 Phase 2
21 Laparoscopic Gastrectomy for Advanced Gastric Cancer Completed NCT01441336 Phase 2
22 Laparoscopic Sentinel Node Navigation Surgery for Gastric Cancer Completed NCT01441310 Phase 2
23 The Safety and Feasibility of Reduced Port Robotic Distal Gastrectomy Using Single-site for Surgical Treatment of Early Gastric Cancer Completed NCT02347956 Phase 1, Phase 2
24 A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Evaluate the Analgesic Efficacy and Safety of VVZ-149 Injection for Post-operative Pain Following Laparoscopic-assisted Gastrectomy in Early Gastric Cancer Patients Completed NCT02522598 Phase 2 VVZ-149 injections;Placebo
25 A Phase-II Clinical Trial of Laparoscopy-Assisted Distal Gastrectomy With D2 Lymph Node Dissection for Gastric Cancer Completed NCT01163812 Phase 2
26 Randomized Phase II Study of FOLFOX Followed by FOLFIRI or Reverse Sequence Treatment in Patients With Advanced or Relapsed Gastric Cancer Completed NCT01138904 Phase 2 irinotecan, oxaliplatin;oxaliplatin, irinotecan
27 A Study to Assess Near Infrared Laparoscopy With Indocyanine Green (ICG) for Intraoperative Lymphatic Imaging and Sentinel Lymph Node Identification During Standard Surgical Resection for Colonic Cancer Completed NCT01662752 Phase 2 Indocyanine green
28 Non-exposure Simple Suturing Endoscopic Full-Thickness Resection (NESS-EFTR) With Laparoscopic Sentinel Lymph Node Navigation for EGC (Senorita3-phase 2) Recruiting NCT03837301 Phase 2
29 Preoperative S-1 Plus Cisplatin-based Chemoradiotherapy for Locally Advanced Resectable Gastric Adenocarcinoma : Randomized, Phase II Trial Recruiting NCT03814759 Phase 2 TS-1 + cisplatin
30 Laparoscopic Versus Open Gastrectomy for Elderly Local Advanced Gastric Cancer Patients: a Phase II Randomized Parallel Controlled Trial Recruiting NCT03564834 Phase 2
31 Prospective Study of Endoscopic Ultrasonographic Staging and Conventional Endoscopic Staging for Depth of Invasion and Endoscopic Tumor Size Estimation for Early Gastric Cancer Unknown status NCT01832246
32 Pilot Study of Non-exposure Simple Suturing EFTR (NESS-EFTR) With Sentinel Lymph Node Navigation for Early Gastric Cancer (Senorita3-pilot) Unknown status NCT03216174
33 Gastric Cancer Screening and Alarm Symptoms in Early Gastric Cancer Unknown status NCT01659632
34 The Feasible Research of Infrared Endoscope to Diagnose Early Gastric Cancer and Evaluate the Invasive Depth of Tumors Unknown status NCT02710838
35 Long-term Follow-up After Endoscopic Submucosal Dissection for Early Gastric Cancer Unknown status NCT01132469
36 Difference in H. Pylori Infection Rate of EGC Patients Before and After Endoscopic Resection Unknown status NCT02090062
37 Clinical Study for the Impact of Bio-absorbable Felt (NEOVEIL®) With Fibrin Sealant on Removal of Drainage Tube After Minimally Invasive Gastrectomy for Gastric Cancer: Multicenter Prospective Randomized Comparison Study Unknown status NCT01742806
38 Standardization of D2 Lymphadenectomy and Surgical Quality Control for KLASS-02 Trial: KLASS-02-QC Unknown status NCT01283893
39 Comparison of Proton Pump Inhibitor and H2 Receptor Blocker on Prevention of Bleeding From Iatrogenic Ulcer After Endoscopic Submucosal Dissection for Gastric Neoplasms: A Prospective Randomized Controlled Trial Unknown status NCT01179724 high dose proton pump inhibitor;H2RB
40 Probe-based Confocal Laser Endomicroscopy for the Diagnosis of Gastric Intestinal Metaplasia,Intraepithelial Neoplasia,and Carcinoma:A Multicenter,Randomized,Controlled Trial Unknown status NCT02515721
41 An Educational Intervention, the First Step of the Train the Trainer (TTT) Plan, to Improve the Young Endoscopist's Ability to Find the Early Gastric Cancer:Prospective Study With Historical Control Unknown status NCT02385578
42 The Learning Curve of Probe-based Confocal Laser Endomicroscopy (pCLE) Images Interpretation in Gastric Intestinal Metaplasia(GIM) Unknown status NCT01491724
43 Pilot Trial on Efficacy of Single Dose Perioperative Intravenous Dexamethasone for Pain Relief After Endoscopic Submucosal Dissection Unknown status NCT02037399 intravenous dexamethasone;intravenous normal saline
44 Laparoscopic Reinforcement Suture (LARS) on Staple-line of Duodenal Stump Using Barbed Suture in Laparoscopic Gastrectomy for Gastric Cancer: A Prospective Single Arm Phase II Study Unknown status NCT03085199
45 The Effect and Mechanism of Improving Diabetes by Reconstruction Methods in Gastric Cancer Patients With DM Who Receive Surgical Treatment Unknown status NCT01375738
46 Serum Cholesterol and Gastric Neoplasm: Nested Case-control Study Unknown status NCT02041312
47 Screening and Triage Test for Early Detection of Gastric Cancer Unknown status NCT01774266
48 Effect of Gastrectomy and Anastomosis on Chronic Metabolic Disease Such as Diabetes and Hypertension in Early Gastric Cancer Patients Completed NCT01643811
49 Prospective Randomized Trial Comparing Endoscopic Submucosal Dissection Against Laparoscopic Assisted Gastrectomy for Treatment of Early Gastric Cancer Completed NCT03136354
50 Quality Control Study for Multicenter Phase III Trial of Laparoscopic Sentinel Node Biopsy and Stomach Preserving Surgery in Early Gastric Cancer Completed NCT01544413

Search NIH Clinical Center for Microinvasive Gastric Cancer

Sources

Genetic Tests for Microinvasive Gastric Cancer

About this section
Sources

Anatomical Context for Microinvasive Gastric Cancer

About this section

MalaCards organs/tissues related to Microinvasive Gastric Cancer:

41
Lymph Node, Liver, Colon, Bone, Testes, Spleen, Bone Marrow
Sources

Publications for Microinvasive Gastric Cancer

About this section

Articles related to Microinvasive Gastric Cancer:

(show top 50) (show all 4410)
# Title Authors PMID Year
1
Vascular endothelial growth factor-C and -D expression correlates with lymph node micrometastasis in pN0 early gastric cancer. 9 38
19117016 2009
2
Histopathological predictor for regional lymph node metastasis in gastric cancer. 9 38
19104832 2009
3
Cyclooxygenase-2 mediated regulation of E-cadherin occurs in conventional but not early-onset gastric cancer cell lines. 9 38
19940363 2009
4
Comparison of the validity of three biomarkers for gastric cancer screening: carcinoembryonic antigen, pepsinogens, and high sensitive C-reactive protein. 9 38
18648315 2009
5
[Expression of epithelial cadherin in early gastric cancer and its correlation to lymph node micrometastasis and clinicopathologic features]. 9 38
17672949 2007
6
[Clinicopathological and biological features of micrometastasis in early gastric cancers]. 9 38
17571311 2007
7
[Effect of surgical manipulation on the dissemination of cancer cells into peripheral blood in patients with gastric cancer and its risk factor analysis]. 9 38
17520381 2007
8
Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies. 9 38
17261130 2007
9
Detection of lymph node micrometastasis in pN0 early gastric cancer: efficacy of duplex RT-PCR with MUC2 and TFF1 in mucosal cancer. 9 38
16820924 2006
10
Histologic and serum risk markers for noncardia early gastric cancer. 9 38
15688378 2005
11
Syndecan-1 and E-cadherin expression in differentiated type of early gastric cancer. 9 38
15902740 2005
12
Circulating level of hepatocyte growth factor as a useful tumor marker in patients with early-stage gastric carcinoma. 9 38
15513361 2004
13
[Expression of beta-catenin and E-cadherin in early gastric cancer: correlation with clinicopathologic parameters]. 9 38
14978364 2004
14
[Studies of promoter methylation status and protein expression of E-cadherin gene in associated progression stages of gastric cancer]. 9 38
12776596 2003
15
The CagA protein of Helicobacter pylori is translocated into epithelial cells and binds to SHP-2 in human gastric mucosa. 9 38
12552462 2003
16
Relationship between gastric disease and deletion of cag pathogenicity island genes of Helicobacter pylori in gastric juice. 9 38
12645789 2003
17
Evaluation of carcinoembryonic antigen mRNA in living, necrotic, and apoptotic gastric cancer cells by reverse transcriptase-polymerase chain reaction. 9 38
14605956 2003
18
Abnormal expression of E-cadherin and beta-catenin may be a molecular marker of submucosal invasion and lymph node metastasis in early gastric cancer. 9 38
11856141 2002
19
BGP expression in gastric epithelium and early gastric cancer. 9 38
12378336 2002
20
BGP expression in gastric biopsies may predict the development of new lesions after local treatment for early gastric cancer. 9 38
12378338 2002
21
Significant correlation between micrometastasis in the lymph nodes and reduced expression of E-cadherin in early gastric cancer. 9 38
11706763 2001
22
[A case of radiologically negative small-cell lung carcinoma successfully detected early by whole-body FDG-PET]. 9 38
11296386 2001
23
Changes in the E-cadherin-catenin complex expression in early and advanced gastric cancers. 9 38
11684825 2001
24
Expression of the E-cadherin/catenin (alpha-, beta-, and gamma-) complex correlates with the macroscopic appearance of early gastric cancer. 9 38
11113859 2000
25
Detection of tumor cell contamination in peripheral blood by RT-PCR in gastrointestinal cancer patients. 9 38
10642939 1999
26
Loss of E-cadherin expression in early gastric cancer. 9 38
10231415 1999
27
[The expression of thymidylate synthase and thymidine phosphorylase in the early-stage of gastric cancer]. 9 38
10065095 1999
28
Cooccurrence of reduced expression of alpha-catenin and overexpression of p53 is a predictor of lymph node metastasis in early gastric cancer. 9 38
10461060 1999
29
The expression of cadherin-catenin complex in association with the clinicopathologic features of early gastric cancer. 9 38
9681606 1998
30
High prevalence of the CagA-positive Helicobacter pylori strains in Japanese asymptomatic patients and gastric cancer patients. 9 38
9175208 1997
31
Single-cell mutation analysis of tumors from stained histologic slides. 9 38
8973475 1996
32
Intratumoral heterogeneity and inverse correlation between expression of E-cadherin and collagenase type IV in human gastric carcinomas. 9 38
8641546 1996
33
Effect of Tailored Perigastric Lymph Node Dissection on Gastric Motility in a Canine Model. 38
31096107 2019
34
Natural History of Gastric Cancer: Observational Study of Gastric Cancer Patients Not Treated During Follow-Up. 38
31190210 2019
35
A prediction model for lymph node metastasis in early-stage gastric cancer: Toward tailored lymphadenectomy. 38
31301150 2019
36
Epstein-Barr virus status is a promising biomarker for endoscopic resection in early gastric cancer: proposal of a novel therapeutic strategy. 38
30826866 2019
37
Oncological feasibility of laparoscopic subtotal gastrectomy compared with laparoscopic proximal or total gastrectomy for cT1N0M0 gastric cancer in the upper gastric body. 38
30830641 2019
38
Objective Assessment of the Utility of Chromoendoscopy with a Support Vector Machine. 38
29504086 2019
39
Clinicopathologic parameters associated with the FDG-avidity in staging of early gastric cancer using 18F-FDG PET. 38
31374056 2019
40
Prospective cohort study of patients with early gastric cancer to detect prodromal Parkinson disease (EGC-PPD): A study protocol and baseline characteristics. 38
31153750 2019
41
Validity of additional surgical resection by comparing the operative risk with the stratified lymph node metastatic risk in patients with early gastric cancer after endoscopic submucosal dissection. 38
31382963 2019
42
The diagnostic value of serum gastrokine 1 (GKN1) protein in gastric cancer. 38
31376239 2019
43
Serum microRNA-381: A Potential Marker for Early Diagnosis of Gastric Cancer. 38
31347326 2019
44
Early gastric cancer with ball valve syndrome treated by endoscopic submucosal dissection. 38
30838513 2019
45
Underwater endoscopic mucosal resection for remaining early gastric cancer after endoscopic submucosal dissection. 38
30995684 2019
46
Hsa_circ_0065149 is an Indicator for Early Gastric Cancer Screening and Prognosis Prediction. 38
31432324 2019
47
Additional laparoscopic gastrectomy after noncurative endoscopic submucosal dissection for early gastric cancer: A single-center experience. 38
31413533 2019
48
Utilizing fourth-generation endocytoscopy and the 'enlarged nuclear sign' for in vivo diagnosis of early gastric cancer. 38
31404432 2019
49
Risk Factors for Post-gastric Endoscopic Submucosal Dissection Bleeding with a Special Emphasis on Anticoagulant Therapy. 38
31392471 2019
50
Low Frequency of Lymph Node Metastases in Patients in the United States With Early-stage Gastric Cancers That Fulfill Japanese Endoscopic Resection Criteria. 38
30471457 2019
Sources

Variations for Microinvasive Gastric Cancer

About this section
Sources

Expression for Microinvasive Gastric Cancer

About this section
Search GEO for disease gene expression data for Microinvasive Gastric Cancer.
Sources

Pathways for Microinvasive Gastric Cancer

About this section

Pathways related to Microinvasive Gastric Cancer according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
Gastric cancer 37
Show member pathways
 11.92 TP53 MLH1 CDX2 CDH1
2
Colorectal Cancer Metastasis 64
11.02 TP53 MLH1 CDH1
3
DNA damage_Role of Brca1 and Brca2 in DNA repair 22
10.93 TP53 MLH1 CACNA1E
Sources

GO Terms for Microinvasive Gastric Cancer

About this section

Biological processes related to Microinvasive Gastric Cancer according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 ATP hydrolysis coupled proton transport GO:0015991 9.37 ATP4A ATP12A
2 resolution of meiotic recombination intermediates GO:0000712 9.32 MLH1 EME2
3 cellular sodium ion homeostasis GO:0006883 9.26 ATP4A ATP12A
4 establishment or maintenance of transmembrane electrochemical gradient GO:0010248 9.16 ATP4A ATP12A
5 sodium ion export across plasma membrane GO:0036376 8.96 ATP4A ATP12A
6 cellular potassium ion homeostasis GO:0030007 8.62 ATP4A ATP12A

Molecular functions related to Microinvasive Gastric Cancer according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 sodium:potassium-exchanging ATPase activity GO:0005391 8.96 ATP4A ATP12A
2 potassium:proton exchanging ATPase activity GO:0008900 8.62 ATP4A ATP12A
Sources

Sources for Microinvasive Gastric Cancer

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 TGDB
71 Tocris
72 UMLS
73 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....